Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New and Emerging Targeted Therapies for Vascular Malformations.

American journal of clinical dermatology - 1 Oct 2020

Van Damme An, Seront Emmanuel, Dekeuleneer Valérie, Boon Laurence M, Vikkula Miikka

Abstract excerpt

Vascular malformations are inborn errors of vascular morphogenesis and consist of localized networks of abnormal blood and/or lymphatic vessels with weak endothelial cell proliferation. They have historically been managed by surgery and sclerotherapy. Extensive insight into the genetic origin and molecular mechanism of development has been accumulated over the last 20 years. Since the discovery of the first...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Repositioning

Share to MAP Kinase Signaling System

Share to Phosphoinositide-3 Kinase Inhibitors

Share to Proto-Oncogene Proteins c-akt

Share to TOR Serine-Threonine Kinases

Share to Vascular Malformations

Source

Identifiers

PMID: 32557381
DOI: 10.1007/s40257-020-00528-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New and Emerging Targeted Therapies for Vascular Malformations.PMID 32557381Read ↗

Targeted treatments for vascular malformations: current state of the art.Semantic proximity Read ↗

Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapySemantic proximity Read ↗

Targeted medical therapies for vascular anomaliesSemantic proximity Read ↗

How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.Semantic proximity Read ↗

Development of Molecular Therapies for Venous Malformations.Semantic proximity Read ↗

Molecular landscape and classification of vascular anomalies.Semantic proximity Read ↗

Genetic Basis and Therapies for Vascular Anomalies.Semantic proximity Read ↗

Targeted Therapies for Slow‐Flow Vascular MalformationsSemantic proximity Read ↗

Rapamycin and treatment of venous malformationsSemantic proximity Read ↗

PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials.Semantic proximity Read ↗

Emerging importance of molecular pathogenesis of vascular malformations in clinical practice and classifications.Semantic proximity Read ↗

Systemic Therapy for Vascular Anomalies and the Emergence of Genotype-Guided Management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.